Nick Leschly, President and CEO at bluebird bio, Inc. (BLUE), sold 20,523 shares at $45.46 ($925K) on 2021-01-06, disclosed to the SEC on 2021-01-08.
Seasonal sale ($925k) by President and CEO — this insider has traded BLUE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.95 | 333 | $15K | 1.6% |
| 2 | $44.76 | 5,873 | $263K | 28.4% |
| 3 | $44.76 | 5,873 | $263K | 28.4% |
| 4 | $45.46 | 4,222 | $192K | 20.8% |
| 5 | $45.46 | 4,222 | $192K | 20.8% |
| Total | $45.05 avg | 20,523 |
| $925K |
| 100% |
| Filing → |
| TSVT | SELL | 2024-01-05 | $560K | — | Filing → |
| TSVT | SELL | 2023-08-24 | $102K | — | Filing → |
| TSVT | SELL | 2023-08-07 | $111K | — | Filing → |